Ose patients that completed the clinical trial. Again, these gains are achieved at the expense of higher costs. In fact, considering only drug costs of the comparators under assessment, pregabalin costs 780 more during one year (1,040 for pregabalin vs. 260 for venlafaxine XR). However, if other healthcare resources are included, given the best prognosis of patients taking pregabalin and consequen